Can-Fite BioPharma (CANF) Reports Q1 Loss of NIS0.21/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. FIS
6. DUOL
7. ARM
8. SWKS
9. SPY
10. XYZ

Go back to Can-Fite BioPharma (CANF) Reports Q1 Loss of NIS0.21/Share

Can-Fite Reports First Quarter 2016 Financial Results & Provides Clinical Pipeline Update

May 27, 2016 7:00 AM EDT

PETACH TIKVA, Israel, May 27, 2016 /PRNewswire/ -- Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the three months ended March 31, 2016 and updates on its drug development programs.

Clinical Development Program and Corporate Highlights Include:

CF101 Phase II Glaucoma Results... More